Literature DB >> 34949600

Covid-19: Early studies give hope omicron is milder than other variants.

Bryan Christie1.   

Abstract

Entities:  

Year:  2021        PMID： 34949600     DOI： 10.1136/bmj.n3144

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  39 in total

Review 1.  Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences.

Authors:  Reem Hoteit; Hadi M Yassine
Journal:  Vaccines (Basel)       Date:  2022-06-09

2.  Clinical Profile and Outcome of Hospitalized Confirmed Cases of Omicron Variant of SARS-CoV-2 Among Children in Pune, India.

Authors:  Aarti A Kinikar; Sagar Vartak; Rahul Dawre; Chhaya Valvi; Pragathi Kamath; Naresh Sonkawade; Sameer Pawar; Vaishnavi Bhagat; Kiruthiga A; Komal Nawale; Isha Deshmukh; Rashmita Das; Rajesh K Kulkarni; Varsha Potdar; Rajesh Karyakarte
Journal:  Cureus       Date:  2022-04-30

3.  Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.

Authors:  Javier García-Pérez; María González-Pérez; María Castillo de la Osa; Alberto M Borobia; Luis Castaño; María Jesús Bertrán; Magdalena Campins; Antonio Portolés; David Lora; Mercedes Bermejo; Patricia Conde; Lourdes Hernández-Gutierrez; Antonio Carcas; Eunate Arana-Arri; Marta Tortajada; Inmaculada Fuentes; Ana Ascaso; María Teresa García-Morales; Humberto Erick de la Torre-Tarazona; José-Ramón Arribas; Natale Imaz-Ayo; Eugènia Mellado-Pau; Antonia Agustí; Carla Pérez-Ingidua; Agustín Gómez de la Cámara; Jordi Ochando; Cristobal Belda-Iniesta; Jesús Frías; José Alcamí; Mayte Pérez-Olmeda
Journal:  EClinicalMedicine       Date:  2022-07-01

4.  When might host heterogeneity drive the evolution of asymptomatic, pandemic coronaviruses?

Authors:  Kenichi W Okamoto; Virakbott Ong; Robert Wallace; Rodrick Wallace; Luis Fernando Chaves
Journal:  Nonlinear Dyn       Date:  2022-06-20       Impact factor: 5.741

5.  Decreased Risk of Coronavirus Disease 2019-Related Hospitalization Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Jessica P Ridgway; Samuel Tideman; Bill Wright; Ari Robicsek
Journal:  Open Forum Infect Dis       Date:  2022-06-15       Impact factor: 4.423

6.  COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods.

Authors:  Florian B Mayr; Victor B Talisa; Alexander D Castro; Obaid S Shaikh; Saad B Omer; Adeel A Butt
Journal:  Nat Commun       Date:  2022-06-25       Impact factor: 17.694

7.  The unnaturalistic fallacy: COVID-19 vaccine mandates should not discriminate against natural immunity.

Authors:  Jonathan Pugh; Julian Savulescu; Rebecca C H Brown; Dominic Wilkinson
Journal:  J Med Ethics       Date:  2022-03-07       Impact factor: 5.926

Review 8.  Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic.

Authors:  Rekha Khandia; Shailja Singhal; Taha Alqahtani; Mohammad Amjad Kamal; Nahed A El-Shall; Firzan Nainu; Perumal Arumugam Desingu; Kuldeep Dhama
Journal:  Environ Res       Date:  2022-01-29       Impact factor: 8.431

9.  Impact of therapeutic plasma exchange on acquired vaccinal anti-SARS-CoV-2 antibodies.

Authors:  Catherine Lambert; Anais Scohy; Jean Cyr Yombi; Eric Goffin; Arnaud Devresse
Journal:  Eur J Intern Med       Date:  2022-02-14       Impact factor: 7.749

Review 10.  SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity.

Authors:  Stefan Pilz; Verena Theiler-Schwetz; Christian Trummer; Robert Krause; John P A Ioannidis
Journal:  Environ Res       Date:  2022-02-08       Impact factor: 8.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.